Data prices · Labs & life sciences
What AI labs pay for life sciences data
Health and life sciences data has the clearest public prices of any industry, mostly through Tempus, which disclosed a $200 million three-year data licensing and model development agreement with AstraZeneca and Pathos in 2025. Lab records, protocols and deviations from working labs are scarce, and patient data carries the strictest rules.
What buyers want
Records your team already keeps
01
Results with protocols
Assay results linked to the protocol and conditions that produced them.
02
Deviations and fixes
What went wrong in a run, how it was caught and what changed.
03
Longitudinal records
Data that follows the same subjects or samples over time, with outcomes.
Price signals
What public deals and research show
$200M
Tempus's three-year agreement with AstraZeneca and Pathos for data licensing and model development fees, to build an oncology foundation model (April 2025).
Tempus Q1 2025 results$241.6M
Tempus's 2024 data and services revenue, which includes data licensing and related services.
Tempus FY 2024 resultsThese figures come from a company with millions of linked records and services bundled in. A single lab's records won't price like that, and no public per-record price exists for lab data.
The wider market
$203M
Data licensing contracts Reddit disclosed in early 2024, with terms of two to three years.
TechCrunch$250M+
Reported value of News Corp's five-year content deal with OpenAI, including cash and credits.
Press Gazette$10k-$100k
Per-company payouts for shut-down startups' Slack messages, tickets and email archives, across nearly 100 deals.
Forbes, April 2026$200-$2,000
Typical price per reinforcement learning task, according to Epoch AI's interviews with people who build them.
Epoch AI, 2026Pricing factors
What moves the price
- Outcomes attached
- Molecular or lab data linked to clinical or experimental outcomes is what the largest deals pay for.
- De-identification method
- Patient data must meet HIPAA Safe Harbor or Expert Determination before it can be used, or it stays out.
- Approvals
- Consent and ethics approvals that cover secondary use raise both value and speed.
- Years of history
- Longer runs of records show change over time and how outcomes played out, which a single year can't.
- Rights you can prove
- Buyers pay for data you own or are allowed to license. Data held for customers without their permission won't sell, so our calculator cuts the estimate when rights are unclear.
Our calculator
How we estimate life sciences data
Our indicative model starts from a base value per system for about five years of history at an 11-50 person company, then applies a sector weight of 1.6x, your history, team size and rights. It is an estimate we confirm on a call, not a market price.
| System | Base value |
|---|---|
| Lab notebooks & LIMS | $60k |
| Docs, wikis & SOPs | $10k |
| Support tickets & chat | $15k |
Recurring
Paid again every month
Labs produce new results every week. A refresh term turns each month's new results and deviations into another paid batch.
How recurring revenue worksRules that apply
We leave patient data out unless it is already de-identified under HIPAA or anonymized under your existing approvals.
Source: HHS on HIPAA de-identificationValuation
What is your data worth?
No access to your systems needed. We confirm the number on a 30-minute call.
Questions
Life sciences data, answered
Can we include patient data?
Is the Tempus deal a fair comparison?
What sells best from a working lab?
Keep reading
Selling life sciences dataSelling lab notebook data to AI companies
Lab notebooks sell when they record full conditions and failed runs. How labs value them, what has to be removed first, and how a license works.
6 min read
De-identification vs anonymization
De-identification removes or masks what points to a person. Anonymization means no one can reasonably identify them again. The law treats the two very differently.
5 min read
GDPR and selling data for AI training
Truly anonymous data falls outside the GDPR. Anything still personal needs a lawful basis, a purpose check, clear roles and a transfer mechanism before a lab gets it.
5 min read
Prices in other industries